Target intelligence / Profile preview

Ribosomal RNA processing protein 1 homolog A (RRP1)

Target
RRP1
Molecular classification
Other (nucleolar protein), RNA processing factor
01

Overview

Ribosomal RNA processing protein 1 homolog A (RRP1, also called Nop52 or NNP-1) is an **essential, evolutionarily conserved nucleolar protein** involved in the processing of precursor ribosomal RNA (pre-rRNA) during the biogenesis of the large (60S) ribosomal subunit[1][2]. RRP1/Nop52 mediates late stages of nucleologenesis at the end of mitosis and is required for the maturation of 28S rRNA in humans[2]. It acts as a key mediator in the conversion of large pre-ribosomal particles into functional subunits by facilitating and integrating specific cleavage events in the pre-rRNA, working with factors such as p32, fibrillarin, and exonuclease XRN2[2]. Loss or mutation of RRP1 leads to defects in ribosome biogenesis that ultimately affect protein synthesis and cell growth[1][2]. RRP1 has also emerged as a clinical interest molecule, with distinct transcripts differentially expressed in some cancers and suggested as potential biomarkers for diagnosis and prognosis, for example in neuroblastoma[2]. There are currently no drugs known to specifically target RRP1, and it is not considered a classical therapeutic drug target such as an enzyme, receptor, or ion channel[2].

Other names
Ribosomal RNA processing 1D21S2056ENNP1NNP-1Nop52NOP52RRP1ANovel nuclear protein 1Nucleolar protein Nop52RRP1-like proteinNnp1 homologDNA segment on chromosome 21 (unique) 2056 expressed sequenceNucleolar protein (Drosophila)Protein NNP-1
02

Biological functions

Ribosome biogenesisPre-rRNA processingNucleologenesis (formation of the nucleolus after mitosis)
03

Disease associations

Cancer (proposed biomarker in neuroblastoma and possibly other cancers)Other (fundamental to cell proliferation due to essential role in ribosome assembly)
04

Biomarkers

Expression variants can serve as diagnostic/prognostic markers in cancers such as neuroblastoma

Beyond the preview

Go deeper on Ribosomal RNA processing protein 1 homolog A (RRP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal RNA processing protein 1 homolog A (RRP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call